Tero A H Järvinen Selected Research

Tero A H Järvinen Research Topics

Disease

14	Wounds and Injuries (Trauma) 01/2024 - 02/2006
10	Neoplasms (Cancer) 01/2022 - 04/2003
8	Fibrosis (Cirrhosis) 01/2022 - 12/2010
6	Hypoxia (Hypoxemia) 11/2021 - 06/2011
5	Cicatrix (Scar) 01/2021 - 12/2010
4	Inflammation (Inflammations) 01/2023 - 09/2002
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 09/2016
3	Rupture 11/2017 - 09/2002
3	Breast Neoplasms (Breast Cancer) 11/2006 - 04/2003
2	Keloid 01/2024 - 01/2020
2	Pathologic Neovascularization 04/2023 - 01/2021
2	Papilloma (Papillomatosis) 01/2022 - 12/2019
2	Carcinogenesis 01/2022 - 12/2019
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2020 - 01/2018
2	Retinal Vein Occlusion 01/2020 - 01/2018
2	Pulmonary Arterial Hypertension 02/2014 - 06/2011
2	Carcinoma (Carcinomatosis) 11/2006 - 08/2003
1	Virus Diseases (Viral Diseases) 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Hyperoxia 11/2021
1	Muscular Dystrophies (Muscular Dystrophy) 09/2021
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2020
1	Epidermolysis Bullosa 01/2020
1	Tendon Injuries 01/2018
1	Abdominal Aortic Aneurysm 11/2017
1	Pain (Aches) 09/2002
1	Tendinopathy (Tendonitis) 09/2002

Drug/Important Bio-Agent (IBA)

11	Peptides (Polypeptides)IBA 01/2024 - 02/2006
7	Proteins (Proteins, Gene)FDA Link 04/2023 - 12/2010
7	DecorinIBA 09/2021 - 12/2010
5	CollagenIBA 01/2022 - 09/2002
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 01/2015
4	CytokinesIBA 01/2022 - 07/2015
4	Oxygen (Dioxygen)IBA 11/2021 - 01/2018
3	Syndecan-4IBA 01/2024 - 01/2021
3	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2021 - 01/2020
3	Trastuzumab (Herceptin)FDA Link 11/2006 - 04/2003
2	Triamcinolone (Aristocort)FDA Link 01/2024 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 01/2020
2	Interleukin-13IBA 01/2023 - 01/2022
2	FurinIBA 01/2023 - 01/2018
2	anthraceneIBA 01/2022 - 12/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 09/2002
2	ChemokinesIBA 01/2020 - 01/2019
2	SteroidsIBA 01/2020 - 09/2002
2	Fluorescein (Funduscein)FDA LinkGeneric 08/2007 - 02/2006
2	ErbB Receptors (EGF Receptor)IBA 11/2006 - 08/2003
1	InterleukinsIBA 01/2023
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 01/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	Interleukin-22 (IL-22)IBA 01/2022
1	Interleukin-5 (Interleukin 5)IBA 01/2022
1	cadherin 5IBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Collagen Type I (Type I Collagen)IBA 01/2021
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 07/2020
1	Protons (Proton)IBA 07/2020
1	Carbon DioxideIBA 07/2020
1	Bicarbonates (Hydrogen Carbonate)IBA 07/2020
1	Hormones (Hormone)IBA 01/2020
1	Nonmuscle Myosin Type IIAIBA 01/2018
1	Crystallins (Crystallin)IBA 01/2018
1	Retinaldehyde (Retinal)IBA 01/2018
1	FilaminsIBA 01/2018
1	AntibodiesIBA 07/2017
1	LigandsIBA 07/2017
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 07/2017
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2016
1	Human Serum Albumin FDA LinkGeneric 09/2016
1	ras ProteinsIBA 07/2015
1	Vasodilator Agents (Vasodilators)IBA 02/2014
1	IntegrinsIBA 01/2013
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2013
1	MonocrotalineIBA 06/2011
1	Semaxinib (SU5416)IBA 06/2011
1	Peptide LibraryIBA 08/2007
1	IceIBA 04/2007
1	estropipate (Ogen)FDA LinkGeneric 02/2006
1	Blood Proteins (Serum Proteins)IBA 02/2006
1	FibrinIBA 02/2006
1	Fibrinogen (Factor I)FDA Link 02/2006
1	Fibronectins (Fibronectin)IBA 02/2006
1	AnthracyclinesIBA 04/2003

Therapy/Procedure

9	Therapeutics 01/2024 - 11/2006
3	Injections 01/2024 - 09/2002
2	Drug Therapy (Chemotherapy) 08/2003 - 04/2003
1	Aftercare (After-Treatment) 01/2024
1	Intralesional Injections 01/2024
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Splints (Splint) 01/2019
1	Intravenous Administration 06/2011
1	First Aid (Aids, First) 04/2007
1	Combination Drug Therapy (Combination Chemotherapy) 11/2006